标题
Mevalonate Metabolism in Cancer Stemness and Trained Immunity
作者
关键词
-
出版物
Frontiers in Oncology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-09-20
DOI
10.3389/fonc.2018.00394
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Deficiency of primary cilia in kidney epithelial cells induces epithelial to mesenchymal transition
- (2018) Sang Jun Han et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling
- (2018) Debanjan Dhar et al. CANCER CELL
- Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity
- (2018) Ioannis Mitroulis et al. CELL
- BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis
- (2018) Eva Kaufmann et al. CELL
- Metabolic Induction of Trained Immunity through the Mevalonate Pathway
- (2018) Siroon Bekkering et al. CELL
- Molecular Determinants of Target Cell Recognition by Human γδ T Cells
- (2018) André E. Simões et al. Frontiers in Immunology
- Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer
- (2017) Marco Sciacovelli et al. FEBS Journal
- Cilia loss sensitizes cells to transformation by activating the mevalonate pathway
- (2017) Yue-Zhen Deng et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF–mediated myelopoiesis
- (2017) Peer W.F. Karmaus et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights
- (2017) Heming Li et al. Molecular Cancer
- Mechanical cues control mutant p53 stability through a mevalonate–RhoA axis
- (2017) Eleonora Ingallina et al. NATURE CELL BIOLOGY
- Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
- (2017) Charli Dominguez et al. SEMINARS IN CANCER BIOLOGY
- An epithelial-to-mesenchymal transition-inducing potential of granulocyte macrophage colony-stimulating factor in colon cancer
- (2017) Yaqiong Chen et al. Scientific Reports
- Mevalonate Metabolism in Immuno-Oncology
- (2017) Georg Gruenbacher et al. Frontiers in Immunology
- Mevalonate metabolism governs cancer immune surveillance
- (2017) Georg Gruenbacher et al. OncoImmunology
- Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
- (2017) Andrea Morandi et al. Frontiers in Oncology
- Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer
- (2016) Renate Pichler et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
- (2016) Michael D. Buck et al. CELL
- Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity
- (2016) Rob J.W. Arts et al. Cell Metabolism
- IL-7/IL-7 receptor axis stimulates prostate cancer cell invasion and migration via AKT/NF-κB pathway
- (2016) Hu Qu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Nuclear Phosphoproteomic Screen Uncovers ACLY as Mediator of IL-2-induced Proliferation of CD4+T lymphocytes
- (2016) Nerea Osinalde et al. MOLECULAR & CELLULAR PROTEOMICS
- Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
- (2016) Junli Deng et al. Oncotarget
- Ecto-ATPase CD39 Inactivates Isoprenoid-Derived Vγ9Vδ2 T Cell Phosphoantigens
- (2016) Georg Gruenbacher et al. Cell Reports
- Transcriptional Profiling Reveals a Common Metabolic Program in High-Risk Human Neuroblastoma and Mouse Neuroblastoma Sphere-Forming Cells
- (2016) Mengling Liu et al. Cell Reports
- ATP Citrate Lyase (ACLY): A Promising Target for Cancer Prevention and Treatment
- (2015) Amrita Khwairakpam et al. CURRENT DRUG TARGETS
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion
- (2014) Katsuhiko Warita et al. Scientific Reports
- MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
- (2014) M. Gabay et al. Cold Spring Harbor Perspectives in Medicine
- Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism
- (2014) Georg Gruenbacher et al. OncoImmunology
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
- (2013) Marko Babjuk et al. EUROPEAN UROLOGY
- GATA-3 controls the maintenance and proliferation of T cells downstream of TCR and cytokine signaling
- (2013) Yunqi Wang et al. NATURE IMMUNOLOGY
- MYC, Metabolism, Cell Growth, and Tumorigenesis
- (2013) C. V. Dang Cold Spring Harbor Perspectives in Medicine
- Rasgrp1 mutation increases naïve T-cell CD44 expression and drives mTOR-dependent accumulation of Helios+ T cells and autoantibodies
- (2013) Stephen R Daley et al. eLife
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by T lymphocytes
- (2011) O. Nussbaumer et al. BLOOD
- IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells
- (2011) R. I. Fernando et al. CANCER RESEARCH
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation
- (2011) Ruoning Wang et al. IMMUNITY
- CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
- (2011) Rhonda L. Brown et al. JOURNAL OF CLINICAL INVESTIGATION
- Membrane lipidome of an epithelial cell line
- (2011) Julio L. Sampaio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- -catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness
- (2011) E. Sanchez-Tillo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-2 Costimulation Enables Statin-Mediated Activation of Human NK Cells, Preferentially through a Mechanism Involving CD56+ Dendritic Cells
- (2010) G. Gruenbacher et al. CANCER RESEARCH
- Dysregulation of the mevalonate pathway promotes transformation
- (2010) J. W. Clendening et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD56+ human blood dendritic cells effectively promote TH1-type T-cell responses
- (2009) G. Gruenbacher et al. BLOOD
- T cell factor 1 initiates the T helper type 2 fate by inducing the transcription factor GATA-3 and repressing interferon-γ
- (2009) Qing Yu et al. NATURE IMMUNOLOGY
- Dual and opposing roles of primary cilia in medulloblastoma development
- (2009) Young-Goo Han et al. NATURE MEDICINE
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- LXR Signaling Couples Sterol Metabolism to Proliferation in the Acquired Immune Response
- (2008) Steven J. Bensinger et al. CELL
- NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin
- (2008) Francois Lehembre et al. EMBO JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation